ForumIAS LATEST
- SFG FRC 2027 | Program starts from 15th Dec. 2026 | Admissions open for Tranche-1 Entrance Test till 25th Oct. 2026 Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 21st October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News: An old drug formulation RLF-100 or Aviptadil is being probed to treat Covid-19 patients after initial studies have shown that the drug is able to halt SARS-CoV-2 virus replication in lungs.
Facts:
- RLF-100 or Aviptadil: It is an old proprietary drug formulation of synthetic human Vasoactive Intestinal Polypeptide(VIP).
Additional Facts:
- Vasoactive Intestinal Polypeptide (VIP): It is released throughout the body but remains mostly concentrated in lungs.
- Significance of VIP:
- It is produced by immune cells and nerve endings and acts as a neurotransmitter.
- It helps improve muscle activity and blood flow in the gastrointestinal tract.
- It has anti-inflammatory and anti-cytokine activity properties that can help in alleviating respiratory distress in COVID19 patients.
